Diagnostics
- Ref-No. Technology
-
01-01030
Rapid quantitation of virus-neutralizing antibodies in biosamples - a novel BSL1 approach based on virus-like particles (VLPs)
-
01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
-
02-00324
Innovative DOTA-Linkers for Bacterial Targeting
-
02-00351
Increased Availability and Efficacy of Aminoglycosides
-
02-00375
CRISPRdetect – multiplexed RNA detection with reprogrammed tracrRNAs
-
02-00396
Novel Lectin-Targeting therapeutics and diagnostics for Pseudomonas aeruginosa infections
-
02-00413
Rapid Detection of Shiga toxin producing E.coli (STEC)
-
02-00434
Programmable RNA-Guided Enzymes and Novel Orthogonal Substrates for Crispr Diagnostics
- 03-00367 Targeting of Autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer’s and vascular dementia
-
03-00448
Method and kit for early detection of preeclampsia
-
03-00459
Autofocus-control of a microscope including an electrically tunable lens
-
03-00462
3D-Seq: Localizing Spatial Gene Expression in 3-Dimensions on Single Cell-Level
-
03-00470
FLAM-Seq: Genome-wide full-length mRNA and poly(A)-tail sequencing
-
03-00471
A FRET-based method to measure seeding activity of misfolded protein species in complex biological samples
-
03-00523
Diagnostic assay for determination of personal microbial metabolite production profile for nutritional adjustment
-
10-00126
Cytotoxicity Assay for detecting Cellular Damage
-
10-00128
Functionalized Nanoparticles for Viral Clearance
- 14-00013 MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
- 14-00022 Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
-
14-00128
Blood-based tuberculosis precision medicine: transcriptomic model shortens therapy duration
-
14-00135
Epigenetic detection of early-stage non-small cell lung cancer in blood
-
14-00142
Flow cytometric basophil activation test for automated, high-throughput allergy diagnostics
-
14-00169
Blood-based tuberculosis precision medicine: transcriptomic model predicts treatment response
-
14-00173
Replacement of allergen challenge: Safely scoring prevalence & severity of allergies
-
15-00366
LncRNA LIPCAR predicts disease progression in heart failure and myocardial infarction patients
-
15-00411
Novel diagnostic for Peripartum cardiomyopathy (PPCM) in pregnant women
-
15-00502
Predicting the therapeutic effect of compositions containing BH3 mimetics
-
15-00565
Time-efficient assessment of pulmonary function via CT with low radiation doses
-
15-00604
Novel Diagnostic Marker For Early Detection Of Bladder Cancer
- 15-00612 TCR-agnostic identification of tumor-specific T cells for cancer diagnostics and therapy
-
15-00652
Biomarker Panel for Diagnosing Pulmonary Dysfunction
-
23-00046
microRNA Signature Indicates Risk for Cognitive Decline
-
32-00056
Non-invasive measurement of myocardial power
-
32-00081
Non-invasive pressure gradient prediction for a cardiovascular narrowing
-
32-00128
Method for Assessing Out-of-Specification (OOS) CAR T-Cell Products and Predicting Patient Response
-
32-00187
HSV signature antibodies predict the development of anti-NMDA receptor encephalitis
-
33-00002
Rapid, simultaneous and non-destructive blood diagnostics using a multi-omics NMR platform
-
33-00015
The Prognostic Umbilical Swab: A Rapid Molecular Risk Stratification Tool for Neonatal Sepsis and Brain Injury
-
42-00070/42-00080
Liver Function imaging of the functional hepatic reserve
-
42-00086
FAP-targeted dual imaging for guided cancer surgery
-
43-00016
SARSeq: Multiplexed, parallel detection of SARS-CoV2 variants and other viruses in high-throughput
-
43-00026
Efficient multiplex cryo-embedding method for cost-efficient, high-throughput tissue analysis
-
43-00034
Biomarker set for early and non-invasive diagnosis and differentiation of renal cell carcinomas
